Moderna Inc.’s chairman says the Trump administration’s vaccine policy changes are part of a broader attack on science that may have only just begun.
Moderna Inc. shares rose after the company posted a narrower third-quarter loss than Wall Street expected, a sign that its cost-cutting measures are helping offset the decline of its COVID business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results